Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where T. R. Doel is active.

Publication


Featured researches published by T. R. Doel.


Vaccine | 1990

Isotype responses of infected, virus-vaccinated and peptide-vaccinated cattle to foot-and-mouth disease virus

G. Mulcahy; C. Gale; P. Robertson; S. Iyisan; Richard D. DiMarchi; T. R. Doel

An ELISA to measure bovine serum immunoglobulin isotypes (IgG1, IgG2, IgM and IgA) specific for foot-and-mouth disease virus (FMDV) or for synthetic FMDV peptides is described. Sera from cattle infected by FMDV, vaccinated with conventional inactivated virus vaccines or vaccinated with synthetic peptides were examined using this assay. Generally IgG subclasses dominated the antibody responses of all groups after an early IgM response had waned. An exception to this pattern was seen in the case of a group of immature calves given multiple or high doses of synthetic peptide and in which levels of IgM continued to rise until the end of the experimental period. Both infected animals and those vaccinated with inactivated virus mounted antibody responses in which IgG1 titres tended to predominate over those of IgG2. In some infected animals, an early IgG2 response was evident but resolution of lesions and clinical recovery did not occur until IgG1 antibody appeared in the serum some days later. In synthetic-peptide immunized animals the response was more variable but IgG1:IgG2 ratios at 21 days postvaccination were significantly lower than those of virus-vaccinated animals. It is proposed that differences in the isotype profiles induced by conventional FMD vaccines and those resulting from vaccination of cattle with synthetic FMDV peptides may in part account for the lower protective index of peptide-induced antibodies.


Journal of General Virology | 1989

T cell-dependent induction of antibody against foot-and-mouth disease virus in a mouse model.

T. Collen; L. Pullen; T. R. Doel

Nude and normal BALB/c mice were primed by intravenous inoculation of purified, infectious foot-and-mouth disease virus (FMDV) type A24, strain Cruzeiro. Frequency estimation of antigen-specific antibody-secreting cells (ASC) and Thy 1+ T cells in the spleens of immunized mice identified that the IgM response was similar for both nude and normal mice, whereas substantial numbers of both IgG ASC and Thy 1+ cells were present in normal mice only. In contrast, nude and normal mouse sera both contained IgG although the nude mouse serum was deficient in IgG1. Antigen-specific antibody could not be induced in spleen cell cultures from C57BL/6 mice after depletion of T cells with monoclonal antibody plus complement. However, the antibody response could be reconstituted if either a source of exogenous lymphokines or T cells from primed but not unprimed mice were added. Similarly, polyclonal stimulation or unprimed T cells could restore the in vitro response and thus complemented the finding of a low frequency of helper T cells in unprimed mice. Taken together, these data identify that the induction of IgG in FMDV-immunized mice is T cell-dependent and regulated by lymphokines. Furthermore, in nude mice a site other than the spleen must be responsible for the synthesis of the observed serum IgG.


Vaccine | 1991

Mouse protection test as a predictor of the protective capacity of synthetic foot-and-mouth disease vaccines

G. Mulcahy; L.A. Pullen; C. Gale; Richard D. DiMarchi; T. R. Doel

A passive immunity test (MPT) in suckling mice for the quantification of protective anti-foot-and-mouth disease virus (FMDV) antibodies in serum is described. Comparisons with titres obtained using conventional serum neutralization tests show that for cattle given synthetic peptide vaccines this in vivo assay is a better indicator of protection, while for convalescent animals and virus-vaccinates both tests are equally valid predictors of immune status. Cleavage of Fc fragments from anti-virus or anti-peptide IgG results in a marked decrease in MPT titres although binding to virus in ELISA is unaffected, indicating that intact antibodies are required for in vivo clearance of FMDV. Cross-protection studies demonstrate that anti-peptide sera, while less potent than anti-viral sera in conferring passive immunity against FMDV challenge, have a wider protective range than anti-viral sera within the O serotype and also between O and A serotypes. Possible qualitative differences between anti-viral and anti-peptide sera are discussed in the light of these findings.


Research in Veterinary Science | 1992

Maturation of functional antibody affinity in animals immunised with synthetic foot-and-mouth disease virus

G. Mulcahy; E. Reid; Richard D. DiMarchi; C. Gale; T. R. Doel

A good correlation exists between specific neutralising antibody titre and protection against challenge with foot-and-mouth disease virus (FMDV) in infected or virus-vaccinated cattle, but not in the case of animals immunised with synthetic FMDV peptides. Therefore, mechanisms other than simple neutralisation are likely to be important in vivo. Antibody affinity may influence the protective capacity of sera from immunised animals and experiments were carried out to measure the functional affinity for synthetic FMDV peptide of sera from guinea pigs and cattle given various synthetic vaccines. In guinea pigs given a single dose of synthetic vaccine, antibody affinity increased with time after immunisation. In cattle, however, administration of a second dose of peptide 21 days after the first markedly retarded the process of affinity maturation. For guinea pig sera of equivalent neutralising activity, those of higher functional affinity had higher protective indices than those of lower functional affinity. Knowledge of the importance of antibody affinity in protection against FMD is important for an improved understanding of the mechanisms of protection and for the design of novel vaccines.


Science | 1986

Protection of cattle against foot-and-mouth disease by a synthetic peptide

Richard D. DiMarchi; Gerald Stephen Brooke; C. Gale; V Cracknell; T. R. Doel; N Mowat


Journal of Immunology | 1991

A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle.

T Collen; Richard D. DiMarchi; T. R. Doel


Immunology | 1991

High-affinity antibody induced by immunization with a synthetic peptide is associated with protection of cattle against foot-and-mouth disease.

M W Steward; C M Stanley; Richard D. DiMarchi; G. Mulcahy; T. R. Doel


Immunology | 1991

MHC class II restricted recognition of FMDV peptides by bovine T cells

Elizabeth Glass; Ra Oliver; T Collen; T. R. Doel; Richard D. DiMarchi; R. L. Spooner


Journal of Virology | 1990

Heterotypic protection induced by synthetic peptides corresponding to three serotypes of foot-and-mouth disease virus.

T. R. Doel; C. Gale; C. M. C. F. do Amaral; G. Mulcahy; Richard D. DiMarchi


Journal of General Virology | 1988

Immunization against foot-and-mouth disease with synthetic peptides representing the C-terminal region of VP1.

T. R. Doel; C. Gale; Gerald Stephen Brooke; Richard D. DiMarchi

Collaboration


Dive into the T. R. Doel's collaboration.

Top Co-Authors

Avatar

Richard D. DiMarchi

Indiana University Bloomington

View shared research outputs
Top Co-Authors

Avatar

C. Gale

Eli Lilly and Company

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge